🩹 Category
Healing & Recovery Peptides
Peptides investigated for tissue repair — tendons, ligaments, muscle, and the gut lining. Largely animal research.
Peptides investigated for tissue repair — tendons, ligaments, muscle, and the gut lining. Largely animal research.
Healing and recovery peptides are studied for their effects on tissue repair — tendons, ligaments, muscle, the gut lining, and bone. This category mixes two very different worlds. On one side are popular "research chemicals" like BPC-157 and TB-500, hugely popular in fitness circles but supported almost entirely by animal studies, with no completed human trials. On the other are genuinely approved peptide medicines for specific repair-related conditions.
Among the approved drugs here: teduglutide (a GLP-2 analog that regrows intestinal lining in short bowel syndrome) and the bone-building osteoporosis agents teriparatide and abaloparatide. Reading these pages side by side is a useful lesson in the gap between a compound that "works in mice" and one proven in people.
A synthetic peptide fragment that has become one of the most studied “healing” peptides in animal research, though it has not completed human clinical trials.
Read the guide →A synthetic peptide related to Thymosin Beta-4, an actin-binding protein involved in cell migration and tissue repair.
Read the guide →A naturally occurring copper-binding tripeptide that declines with age and is widely used in cosmetic skincare for its collagen and skin-repair signaling.
Read the guide →The body's main cathelicidin antimicrobial peptide, central to innate immunity and wound healing — but with a complex, context-dependent (and sometimes harmful) biology.
Read the guide →A tripeptide fragment of α-MSH studied for anti-inflammatory effects, particularly in the gut and skin, without α-MSH's pigmentation activity.
Read the guide →The full naturally occurring 43-amino-acid protein that regulates actin and tissue repair — the parent molecule that the popular “TB-500” is a fragment/analog of.
Read the guide →A peptide derived from the tissue-protective region of erythropoietin (EPO) — without EPO's red-blood-cell effects — studied in trials for neuropathic pain and small-fiber neuropathy.
Read the guide →An oral peptide that regulates intestinal tight junctions (“leaky gut”), studied most for celiac disease — it reached Phase 3, though that trial did not meet its primary endpoint.
Read the guide →A GLP-2 receptor agonist and FDA-approved drug (Gattex) that promotes intestinal growth and absorption in people with short bowel syndrome.
Read the guide →A recombinant fragment of parathyroid hormone (PTH 1–34) and FDA-approved anabolic drug (Forteo) that builds new bone in people with osteoporosis at high fracture risk.
Read the guide →A PTH-related protein analog and FDA-approved anabolic drug (Tymlos) that stimulates new bone formation in people with osteoporosis at high fracture risk.
Read the guide →A minimally absorbed guanylate cyclase-C agonist peptide, FDA-approved (as Linzess) for irritable bowel syndrome with constipation and chronic idiopathic constipation.
Read the guide →A guanylate cyclase-C agonist peptide (Trulance), FDA-approved for chronic idiopathic constipation and IBS with constipation, designed to mimic the natural hormone uroguanylin.
Read the guide →A peptide hormone that lowers blood calcium and slows bone breakdown; the salmon form (Miacalcin, Fortical) is FDA-approved for osteoporosis, Paget's disease, and hypercalcemia.
Read the guide →A gastrointestinal hormone, available as a diagnostic agent (ChiRhoStim), used to assess pancreatic function and gastrin-secreting tumors — and famously studied, then refuted, as an autism treatment.
Read the guide →BPC-157 shows tendon, gut and soft-tissue healing in rodent studies, but there are no completed published human clinical trials, so its effectiveness and safety in people remain unproven. It is also not FDA-approved and is banned in sport.
They are different molecules: BPC-157 derives from a stomach protein and is studied mostly for tendon and gut healing, while TB-500 is a fragment of the actin-regulating protein Thymosin Beta-4 studied for cell migration and broad tissue repair. Neither is approved.
Yes — for specific conditions. Teduglutide is approved for short bowel syndrome, and teriparatide and abaloparatide are approved anabolic (bone-building) drugs for osteoporosis. These are prescription medicines, unlike the unapproved 'recovery' research chemicals.